
New Implant Restores Sight for 5 Million AMD Patients
A breakthrough retinal implant is giving people with age-related macular degeneration their vision back, allowing them to read, use phones, and see loved ones again. More than 80% of patients who received the Prima system can now perform everyday tasks that were impossible before.
Imagine losing the center of your vision so completely that you can't read a text message, recognize faces, or finish a crossword puzzle. That's been the reality for over 5 million people worldwide living with advanced age-related macular degeneration, or AMD. Until now, no treatment could bring their sight back.
The Prima system, approved in Europe this summer and awaiting FDA clearance in the US, is changing everything. This innovative device combines a tiny retinal implant with camera-equipped eyeglasses to restore central vision in AMD patients.
Here's how it works: Special glasses with a miniature camera capture what you're looking at in real time, sending the video to a small handheld processor. That processor converts the images into pulses of near-infrared light and beams them back to a laser projector on the glasses, which shines directly into your eye.
The magic happens at the implant itself. Surgically placed at the back of the eye, the chip contains 378 tiny pixels that act as replacement photoreceptors, the light-sensing cells that AMD destroys. Each pixel has its own electrode and two photovoltaic cells that convert light into electrical signals your remaining healthy eye cells can understand.

What makes Prima especially clever is that it doesn't need batteries. The same photovoltaic cells that create the vision signal also power the entire chip using the infrared light from the glasses. It's a completely self-contained system that works with your body's natural wiring.
The California-based Science Corporation developed Prima by focusing on what AMD leaves behind. "We're leveraging all of the body's own natural functions to process and transmit the information," explains Dr. Frank Brodie, an ophthalmologist at UC San Francisco who serves as Prima's medical director. The disease only kills photoreceptors, leaving the rest of the eye's circuitry intact and ready to work.
The Ripple Effect
After training sessions to learn how to use the system, more than 80% of Prima recipients regained abilities they thought were gone forever. They're reading books again, solving crossword puzzles, checking their phones, and reconnecting with hobbies that require detailed vision.
For millions of people facing a future of increasing blindness, Prima represents hope backed by real results. The device proves that sometimes the best innovations don't fight against the body but work alongside what still functions, turning limitation into possibility.
More Images



Based on reporting by MIT Technology Review
This story was written by BrightWire based on verified news reports.
Building Something New? Try the BrightWire Tech Stack Advisor
Compare modern frameworks, cloud hosting, and AI tools tailored to your project budget and scale.
Spread the positivity!
Share this good news with someone who needs it

